Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-28 @ 4:04 PM
Study NCT ID:
NCT00006104
Status:
COMPLETED
Last Update Posted:
2012-08-14
First Post:
2000-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1998-09
Start Date Type:
None
Primary Completion Date:
2003-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-07
Completion Date Type:
ACTUAL
First Submit Date:
2000-08-03
First Submit QC Date:
None
Study First Post Date:
2003-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-10
Last Update Post Date:
2012-08-14
Last Update Post Date Type:
ESTIMATED